Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1984 Nov;59(11):1061–1063. doi: 10.1136/adc.59.11.1061

First year of life after the use of atenolol in pregnancy associated hypertension.

B Reynolds, L Butters, J Evans, T Adams, P C Rubin
PMCID: PMC1628816  PMID: 6391390

Abstract

We describe the results of a prospective study in which 120 women who developed hypertension in the last trimester of pregnancy were randomly allocated in double blind manner to atenolol or placebo. The mean duration of treatment was five weeks. The only difference between groups during the neonatal period was in respiratory distress syndrome, mainly related to spontaneous premature labour, which occurred in six placebo group babies but in none from the atenolol group. Fifty five children from each group have been followed to 1 year of age. All in the atenolol group are developing normally but one child from the placebo group is brain damaged. These findings do not suggest any short or medium term paediatric complications after the use of beta blockers in pregnancy.

Full text

PDF
1063

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cockburn J., Moar V. A., Ounsted M., Redman C. W. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet. 1982 Mar 20;1(8273):647–649. doi: 10.1016/s0140-6736(82)92202-4. [DOI] [PubMed] [Google Scholar]
  2. Cottrill C. M., McAllister R. G., Jr, Gettes L., Noonan J. A. Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr. 1977 Nov;91(5):812–814. doi: 10.1016/s0022-3476(77)81049-4. [DOI] [PubMed] [Google Scholar]
  3. Dubowitz L. M., Dubowitz V., Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970 Jul;77(1):1–10. doi: 10.1016/s0022-3476(70)80038-5. [DOI] [PubMed] [Google Scholar]
  4. Fiddler G. I. Letter: Propranolol and pregnancy. Lancet. 1974 Sep 21;2(7882):722–723. doi: 10.1016/s0140-6736(74)93301-7. [DOI] [PubMed] [Google Scholar]
  5. Fidler J., Smith V., Fayers P., De Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J (Clin Res Ed) 1983 Jun 18;286(6382):1927–1930. doi: 10.1136/bmj.286.6382.1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gladstone G. R., Hordof A., Gersony W. M. Propranolol administration during pregnancy: effects on the fetus. J Pediatr. 1975 Jun;86(6):962–964. doi: 10.1016/s0022-3476(75)80236-8. [DOI] [PubMed] [Google Scholar]
  7. Habib A., McCarthy J. S. Effects on the neonate of propranolol administered during pregnancy. J Pediatr. 1977 Nov;91(5):808–811. doi: 10.1016/s0022-3476(77)81048-2. [DOI] [PubMed] [Google Scholar]
  8. Lieberman B. A., Stirrat G. M., Cohen S. L., Beard R. W., Pinker G. D., Belsey E. The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. Br J Obstet Gynaecol. 1978 Sep;85(9):678–683. doi: 10.1111/j.1471-0528.1978.tb14946.x. [DOI] [PubMed] [Google Scholar]
  9. Pruyn S. C., Phelan J. P., Buchanan G. C. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol. 1979 Oct 15;135(4):485–489. doi: 10.1016/0002-9378(79)90436-8. [DOI] [PubMed] [Google Scholar]
  10. Redman C. W., Beilin L. J., Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br J Obstet Gynaecol. 1977 Jun;84(6):419–426. doi: 10.1111/j.1471-0528.1977.tb12616.x. [DOI] [PubMed] [Google Scholar]
  11. Redman C. W. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct 9;2(7989):753–756. doi: 10.1016/s0140-6736(76)90597-3. [DOI] [PubMed] [Google Scholar]
  12. Reed R. L., Cheney C. B., Fearon R. E., Hook R., Hehre F. W. Propranolol therapy throughout pregnancy: a case report. Anesth Analg. 1974 Mar-Apr;53(2):214–214. [PubMed] [Google Scholar]
  13. Rubin P. C., Butters L., Clark D. M., Reynolds B., Sumner D. J., Steedman D., Low R. A., Reid J. L. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. 1983 Feb 26;1(8322):431–434. [PubMed] [Google Scholar]
  14. Rubin P. C., Butters L., Reynolds B., Evans J., Sumner D., Low R. A., Reid J. L. Atenolol elimination in the neonate. Br J Clin Pharmacol. 1983 Dec;16(6):659–662. doi: 10.1111/j.1365-2125.1983.tb02237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rubin P. C. Current concepts: beta-blockers in pregnancy. N Engl J Med. 1981 Nov 26;305(22):1323–1326. doi: 10.1056/NEJM198111263052205. [DOI] [PubMed] [Google Scholar]
  16. Woods D. L., Morrell D. F. Atenolol: side effects in a newborn infant. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):691–692. doi: 10.1136/bmj.285.6343.691-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES